Examining the Association between Hemodialysis Access Type and Mortality: The Role of Access Complications

Clinical journal of the American Society of Nephrology: CJASN

Pietro Ravani² 

[1] and..Departments of *Medicine and..†Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada;Departments of *Medicine and..†Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada;§Arbor Research Collaborative for Health, Ann Arbor, Michigan;¶Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan..;‖Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada;‡Department of Medicine, University of Toronto, Toronto, Ontario, Canada

关键词: Arteriovenous Shunt, Surgical;    Australasia;    Central Venous Catheters;    diabetes mellitus;    Europe;    Fistula;    Follow-Up Studies;    Humans;    Male;    North America;    renal dialysis;    Renal Insufficiency;    thrombosis;   

DOI  :  10.2215/CJN.12181116

学科分类：泌尿医学

来源: American Society of Nephrology

【 摘 要 】

Background and objectives People receiving hemodialysis to treat kidney failure need a vascular access (a fistula, a graft, or a central venous catheter) to connect to the blood purification machine. Higher rates of access complications are considered the mechanism responsible for the excess mortality observed among catheter or graft users versus fistula users. We tested this hypothesis using mediation analysis.Design, setting, participants, & measurements We studied incident patients who started hemodialysis therapy from North America, Europe, and Australasia (the Dialysis Outcomes and Practice Patterns Study; 1996–2011). We evaluated the association between access type and time to noninfectious (e.g., thrombosis) and infectious complications of the access (mediator model) and the relationship between access type and time-dependent access complications with 6-month mortality from the creation of the first permanent access (outcome model). In mediation analysis, we formally tested whether access complications explain the association between access type and mortality.Results Of the 6119 adults that we studied (mean age =64 [SD=15] years old; 58% men; 47% patients with diabetes), 50% had a permanent catheter for vascular access, 37% had a fistula, and 13% had a graft. During the 6-month study follow-up, 2084 participants (34%) developed a noninfectious complication of the access, 542 (8.9%) developed an infectious complication, and 526 (8.6%) died. Access type predicted the occurrence of access complications; both access type and complications predicted mortality. The associations between access type and mortality were nearly identical in models excluding and including access complications (hazard ratio, 2.00; 95% confidence interval, 1.55 to 2.58 versus hazard ratio, 2.01; 95% confidence interval, 1.56 to 2.59 for catheter versus fistula, respectively). In mediation analysis, higher mortality with catheters or grafts versus fistulas was not the result of increased rates of access complications.Conclusions Hemodialysis access complications do not seem to explain the association between access type and mortality. Clinical trials are needed to clarify whether these associations are causal or reflect confounding by underlying disease severity.

【 授权许可】

CC BY